Wellnex Leads Healthcare Shares Higher as Neuren and Lumos Deliver Strong News

• Wellnex surged 105.36% after its Pain Away sale could repay all A$10.2 million of debt.
• Neuren gained 26.22% as DAYBUE sales rose 30% and its 2026 royalty forecast increased.
• Lumos climbed 25.00% after receiving a US$767,800 FebriDx purchase order.
• Clinical data drove gains for Clarity, Amplia and Dimerix, while several small-cap stocks fell after sharp opening gaps.